China NT Pharma's Hong Kong IPO Could Trigger Consolidation In Distribution Sector
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - China's largest vaccine promotion and sales services provider is expected to go public on the Hong Kong Stock Exchange April 20, which will likely lead to consolidation in China's distribution sector